| Product Code: ETC10079513 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam Neuroendocrine Tumors Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam Neuroendocrine Tumors Market Revenues & Volume, 2021 & 2031F |
3.3 Vietnam Neuroendocrine Tumors Market - Industry Life Cycle |
3.4 Vietnam Neuroendocrine Tumors Market - Porter's Five Forces |
3.5 Vietnam Neuroendocrine Tumors Market Revenues & Volume Share, By Classification, 2021 & 2031F |
3.6 Vietnam Neuroendocrine Tumors Market Revenues & Volume Share, By Site, 2021 & 2031F |
3.7 Vietnam Neuroendocrine Tumors Market Revenues & Volume Share, By Grade, 2021 & 2031F |
3.8 Vietnam Neuroendocrine Tumors Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.9 Vietnam Neuroendocrine Tumors Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.10 Vietnam Neuroendocrine Tumors Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.11 Vietnam Neuroendocrine Tumors Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Vietnam Neuroendocrine Tumors Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and early diagnosis of neuroendocrine tumors in Vietnam |
4.2.2 Advancements in medical technology and treatment options for neuroendocrine tumors |
4.2.3 Rising healthcare expenditure and improving healthcare infrastructure in Vietnam |
4.3 Market Restraints |
4.3.1 Limited availability of specialized healthcare facilities for neuroendocrine tumor treatment in Vietnam |
4.3.2 High treatment costs and limited insurance coverage for neuroendocrine tumors |
4.3.3 Lack of skilled healthcare professionals specializing in neuroendocrine tumor management in Vietnam |
5 Vietnam Neuroendocrine Tumors Market Trends |
6 Vietnam Neuroendocrine Tumors Market, By Types |
6.1 Vietnam Neuroendocrine Tumors Market, By Classification |
6.1.1 Overview and Analysis |
6.1.2 Vietnam Neuroendocrine Tumors Market Revenues & Volume, By Classification, 2021- 2031F |
6.1.3 Vietnam Neuroendocrine Tumors Market Revenues & Volume, By Functional Net, 2021- 2031F |
6.1.4 Vietnam Neuroendocrine Tumors Market Revenues & Volume, By Non-Functional Net, 2021- 2031F |
6.2 Vietnam Neuroendocrine Tumors Market, By Site |
6.2.1 Overview and Analysis |
6.2.2 Vietnam Neuroendocrine Tumors Market Revenues & Volume, By Lung, 2021- 2031F |
6.2.3 Vietnam Neuroendocrine Tumors Market Revenues & Volume, By Pancreas, 2021- 2031F |
6.2.4 Vietnam Neuroendocrine Tumors Market Revenues & Volume, By Gastrointestinal Tract (GI), 2021- 2031F |
6.2.5 Vietnam Neuroendocrine Tumors Market Revenues & Volume, By Appendicular, 2021- 2031F |
6.3 Vietnam Neuroendocrine Tumors Market, By Grade |
6.3.1 Overview and Analysis |
6.3.2 Vietnam Neuroendocrine Tumors Market Revenues & Volume, By Grade 1, 2021- 2031F |
6.3.3 Vietnam Neuroendocrine Tumors Market Revenues & Volume, By Low-Grade Tumor, 2021- 2031F |
6.3.4 Vietnam Neuroendocrine Tumors Market Revenues & Volume, By Grade 2, 2021- 2031F |
6.3.5 Vietnam Neuroendocrine Tumors Market Revenues & Volume, By Intermediate-Grade Tumor, 2021- 2031F |
6.3.6 Vietnam Neuroendocrine Tumors Market Revenues & Volume, By Grade 3, 2021- 2031F |
6.3.7 Vietnam Neuroendocrine Tumors Market Revenues & Volume, By High-Grade Tumor, 2021- 2031F |
6.4 Vietnam Neuroendocrine Tumors Market, By Type |
6.4.1 Overview and Analysis |
6.4.2 Vietnam Neuroendocrine Tumors Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.4.3 Vietnam Neuroendocrine Tumors Market Revenues & Volume, By Treatment, 2021- 2031F |
6.5 Vietnam Neuroendocrine Tumors Market, By Product |
6.5.1 Overview and Analysis |
6.5.2 Vietnam Neuroendocrine Tumors Market Revenues & Volume, By Somatostatin Analogs, 2021- 2031F |
6.5.3 Vietnam Neuroendocrine Tumors Market Revenues & Volume, By Targeted Therapy, 2021- 2031F |
6.5.4 Vietnam Neuroendocrine Tumors Market Revenues & Volume, By Tyrosine Kinase Inhibitors, 2021- 2031F |
6.5.5 Vietnam Neuroendocrine Tumors Market Revenues & Volume, By mTOR Inhibitors, 2021- 2031F |
6.5.6 Vietnam Neuroendocrine Tumors Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.5.7 Vietnam Neuroendocrine Tumors Market Revenues & Volume, By Antimetabolites, 2021- 2031F |
6.5.8 Vietnam Neuroendocrine Tumors Market Revenues & Volume, By Natural Products, 2021- 2031F |
6.5.9 Vietnam Neuroendocrine Tumors Market Revenues & Volume, By Natural Products, 2021- 2031F |
6.6 Vietnam Neuroendocrine Tumors Market, By Route of Administration |
6.6.1 Overview and Analysis |
6.6.2 Vietnam Neuroendocrine Tumors Market Revenues & Volume, By Oral, 2021- 2031F |
6.6.3 Vietnam Neuroendocrine Tumors Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.7 Vietnam Neuroendocrine Tumors Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 Vietnam Neuroendocrine Tumors Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.7.3 Vietnam Neuroendocrine Tumors Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.7.4 Vietnam Neuroendocrine Tumors Market Revenues & Volume, By Home Healthcare, 2021- 2031F |
6.7.5 Vietnam Neuroendocrine Tumors Market Revenues & Volume, By Home Healthcare, 2021- 2031F |
6.7.6 Vietnam Neuroendocrine Tumors Market Revenues & Volume, By Others, 2021- 2031F |
6.8 Vietnam Neuroendocrine Tumors Market, By Distribution Channel |
6.8.1 Overview and Analysis |
6.8.2 Vietnam Neuroendocrine Tumors Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.8.3 Vietnam Neuroendocrine Tumors Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.8.4 Vietnam Neuroendocrine Tumors Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.8.5 Vietnam Neuroendocrine Tumors Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.8.6 Vietnam Neuroendocrine Tumors Market Revenues & Volume, By Other, 2021- 2031F |
7 Vietnam Neuroendocrine Tumors Market Import-Export Trade Statistics |
7.1 Vietnam Neuroendocrine Tumors Market Export to Major Countries |
7.2 Vietnam Neuroendocrine Tumors Market Imports from Major Countries |
8 Vietnam Neuroendocrine Tumors Market Key Performance Indicators |
8.1 Number of patients diagnosed with neuroendocrine tumors annually |
8.2 Adoption rate of new treatment modalities for neuroendocrine tumors in Vietnam |
8.3 Percentage increase in government funding for neuroendocrine tumor research and treatment in Vietnam |
9 Vietnam Neuroendocrine Tumors Market - Opportunity Assessment |
9.1 Vietnam Neuroendocrine Tumors Market Opportunity Assessment, By Classification, 2021 & 2031F |
9.2 Vietnam Neuroendocrine Tumors Market Opportunity Assessment, By Site, 2021 & 2031F |
9.3 Vietnam Neuroendocrine Tumors Market Opportunity Assessment, By Grade, 2021 & 2031F |
9.4 Vietnam Neuroendocrine Tumors Market Opportunity Assessment, By Type, 2021 & 2031F |
9.5 Vietnam Neuroendocrine Tumors Market Opportunity Assessment, By Product, 2021 & 2031F |
9.6 Vietnam Neuroendocrine Tumors Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.7 Vietnam Neuroendocrine Tumors Market Opportunity Assessment, By End User, 2021 & 2031F |
9.7 Vietnam Neuroendocrine Tumors Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Vietnam Neuroendocrine Tumors Market - Competitive Landscape |
10.1 Vietnam Neuroendocrine Tumors Market Revenue Share, By Companies, 2024 |
10.2 Vietnam Neuroendocrine Tumors Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here